Story perspectives

Families Struggle as Drug Prices Soar Amid Lobbying Wars

12/14/2025

Summary

Story summary

Rising prescription drug costs strain families amid inflation.
A 2022 report shows major pharmaceutical companies earned $112 billion in profits and spent over $10 billion on marketing.
Lobbying for drug pricing policies reached nearly $372 million in 2022, shaping reforms like the Lower Costs, More Cures Act to boost transparency.
Bipartisan reform efforts face resistance from powerful lobbyists, and calls to accountability aim to protect consumers.

1 of 1

Story summary

Rising prescription drug costs strain families amid inflation.
A 2022 report shows major pharmaceutical companies earned $112 billion in profits and spent over $10 billion on marketing.
Lobbying for drug pricing policies reached nearly $372 million in 2022, shaping reforms like the Lower Costs, More Cures Act to boost transparency.
Bipartisan reform efforts face resistance from powerful lobbyists, and calls to accountability aim to protect consumers.